Picture of Axonics logo

AXNX — Axonics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge Cap

Brief: Axonics® Files Pma Supplement With FDA For Fourth Generation Rechargeable Neurostimulator

May 31 (Reuters) - Axonics Inc  AXNX.O :
    * AXONICS® FILES PMA SUPPLEMENT WITH FDA FOR FOURTH
GENERATION
RECHARGEABLE NEUROSTIMULATOR
    * AXONICS INC - ANTICIPATES RECEIVING FDA APPROVAL FOR
FOURTH
GENERATION RECHARGEABLE INS IN Q4 OF 2022
    * AXONICS INC - EXPECTS TO BEGIN SHIPPING NEW DEVICE FOURTH
GENERATION RECHARGEABLE INS TO CUSTOMERS IN Q1 OF 2023

Source text for Eikon:  ID:nBw73JzNqa 
Further company coverage:  AXNX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Axonics

See all news